Company Sangui Biotech International, Inc.

Equities

SBH

US80105B1017

Biotechnology & Medical Research

End-of-day quote Hanseatische Wertpapierboerse Hamburg 07:00:00 2024-03-19 pm EDT 5-day change 1st Jan Change
0.002 EUR -20.00% Intraday chart for Sangui Biotech International, Inc. -.--% -33.33%

Business Summary

Sangui Biotech International, Inc. focuses on the development of pharmaceutical, medical and cosmetic products. The Company develops its products through its German subsidiary, SanguiBioTech AG (Sangui GmbH). It is engaged in seeking to market and selling its products through partnerships with industry partners across the world. It focuses on the development of oxygen carriers capable of providing oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia or blood loss whether due to surgery, trauma, or other causes. It focuses its development and commercialization efforts on such artificial oxygen carriers by reproducing and synthesizing polymers out of native hemoglobin of defined molecular sizes. It offers external applications of oxygen transporters in the medical and cosmetic fields in the form of sprays for the healing of chronic wounds and of gels and emulsions for the regeneration of the skin.

Managers

Managers TitleAgeSince
Chief Executive Officer 62 05-02-06

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 62 05-02-06
Director/Board Member 68 08-12-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 209,955,598 182,538,524 ( 86.94 %) 53,756 ( 0.0256 %) 86.94 %

Shareholders

NameEquities%Valuation
Walter Invest GmbH
0.0333 %
70,000 0.0333 % 280 €

Company contact information

Sangui BioTech International, Inc.

Bleichenbruecke 9

20354, Hamburg

+49 40 609 3120

http://www.sanguibiotech.com
address Sangui Biotech International, Inc.(SBH)
  1. Stock Market
  2. Equities
  3. SBH Stock
  4. Company Sangui Biotech International, Inc.